The rising interest in effective weight management has resulted in considerable investigation into cutting-edge treatments. Lately , Retatrutide, a twin-action GIP and glucagon-like peptide-1 (GLP-1) receptor agonist , has shown encouraging results in medical trials, suggesting potential for considerable weight loss . As a result , many individuals